Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

The Optimal State Scoring Tool: guidance for interdisciplinary care of infants with severe bronchopulmonary dysplasia and its relation to linear growth

Abstract

Objective

Infants with severe bronchopulmonary dysplasia (sBPD) have complex medical courses. We developed the clinician-rated Optimal State Scoring Tool (OSST) that measures factors relevant to clinical improvement of sBPD and investigated preliminary validity using linear growth outcome and OSST scores in sBPD patients.

Methods

Tool development process and pilot findings are provided for 13 patients evaluated longitudinally. OSST scores, length measurements, and steroid dependency values were obtained. Changes in OSST scores and lengths were examined using linear mixed-effect models.

Results

OSST scores were significantly correlated with linear growth (95% CI 0.36, 0.57). The steroid-dependent group showed significantly slower rate of linear growth (95% CI 0.74, 1.05) and slower rate of increase in OSST scores (95% CI 0.99, 2.13) compared to the non-steroid-dependent group, with the OSST showing the largest effect size.

Conclusion

Pilot data reflect promising evidence for OSST construct validity in monitoring clinical outcomes in sBPD patients.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Optimal State Scoring Tool for Severe BPD.
Fig. 2: Phases of BPD (adapted with permission from ref. [7]).
Fig. 3: Length trajectories and OSST total score trajectories.

Similar content being viewed by others

Data availability

All data generated or analyzed during this study are included in this published article [and its supplementary information files]. Research data are confidential.

References

  1. Poindexter BB, Feng R, Schmidt B, Aschner JL, Ballard RA, Hamvas A, et al. Comparisons and limitations of current definitions of bronchopulmonary dysplasia for the prematurity and respiratory outcomes program. Ann Am Thorac Soc. 2015;12:1822–30.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Higgins RD, Jobe AH, Koso-Thomas M, Bancalari E, Viscardi RM, Hartert TV, et al. Bronchopulmonary dysplasia: executive summary of a workshop. J Pediatr. 2018;197:300–8.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Ramel SE, Demerath EW, Gray HL, Younge N, Boys C, Georgieff MK. The relationship of poor linear growth velocity with neonatal illness and two-year neurodevelopment in preterm infants. Neonatology. 2012;102:19–24.

    Article  PubMed  Google Scholar 

  4. Guaman MC, Gien J, Baker CD, Zhang H, Austin ED, Collaco JM. Point prevalence, clinical characteristics, and treatment variation for infants with severe bronchopulmonary dysplasia. Am J Perinatol. 2015;32:960–7.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Logan JW, Burdo-Hartman W, Lynch SK. Optimizing neurodevelopment in severe bronchopulmonary dysplasia. NeoReviews. 2017;18:e598–605.

    Article  Google Scholar 

  6. Bauer SE, Schneider L, Lynch SK, Malleske DT, Shepherd EG, Nelin LD. Factors associated with neurodevelopmental impairment in bronchopulmonary dysplasia. J Pediatr. 2020;218:22–7.e2.

    Article  CAS  PubMed  Google Scholar 

  7. Logan JW, Lynch SK, Curtiss J, Shepherd EG. Clinical phenotypes and management concepts for severe, established bronchopulmonary dysplasia. Paediatr Respir Rev. 2019;31:58–63.

    PubMed  Google Scholar 

  8. Keilt MJ, Logan JW, Backes CH, Reber KM, Nelin LD, Shepherd EG. In-hospital outcomes of later referrals for established bronchopulmonary dysplasia. J Perinatol. 2021;41:1972–82.

    Article  Google Scholar 

  9. Vento G, Tirone C, Paladini A, Lio A, Tana M. Weaning from the ventilator in bronchopulmonary dysplasia. Clin Perinatol. 2021;48:895–906.

    Article  PubMed  Google Scholar 

  10. Pfister KM, Ramel SE. Linear growth and neurodevelopmental outcomes. Clin Perinatol. 2014;41:309–21.

    Article  PubMed  Google Scholar 

  11. Sanchez-Solis M, Perez-Fernandez V, Bosch-Gimenez V, Quesada JJ, Garcia-Marcos L. Lung function gain in preterm infants with and without bronchopulmonary dysplasia. Pediatr Pulmonol. 2016;51:936–42.

    Article  PubMed  Google Scholar 

  12. Abman SH, Collaco JM, Shepherd EG, Keszler M, Cuevas-Guaman M, Welty SE, et al. Interdisciplinary care of children with severe bronchopulmonary dysplasia. J Pediatr. 2017;181:12–28.e1.

    Article  PubMed  Google Scholar 

  13. Boateng GO, Neilands TB, Frongillo EA, Melgar-Quiñonez HR, Young SL. Best practices for developing and validating scales for health, social, and behavioral research: a primer. Front Public Health. 2018;6:149 https://doi.org/10.3389/fpubh.2018.00149.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Natarajan G, Johnson YR, Brozanski B, Farrow KN, Zaniletti I, Padula MA, et al. Postnatal weight gain in preterm infants with severe bronchopulmonary dysplasia. Am J Perinatol. 2014;31:223–30.

    PubMed  Google Scholar 

  15. Meyers JM, Tan S, Bell EF, Duncan AF, Guillet R, Stoll BJ, et al. Neurodevelopmental outcomes among extremely premature infants with linear growth restriction. J Perinatol. 2019;39:193–202.

    Article  CAS  PubMed  Google Scholar 

  16. Lagatta JM, Hysinger EB, Zaniletti I, Wymore EM, Vyas-Read S, Yallapragada S, et al. The impact of pulmonary hypertension in preterm infants with severe bronchopulmonary dysplasia through 1 year. J Pediatr. 2018;203:218–24.e3.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Cuestas E, Aguilera B, Cerutti M, Rizzotti A. Sustained neonatal inflammation is associated with poor growth in infants born very preterm during the first year of life. J Pediatr. 2019;205:91–7.

    Article  PubMed  Google Scholar 

  18. Stavrou S, Nicolaides NC, Critselis E, Darviri C, Charmandari E, Chrousos GP. Paediatric stress: from neuroendocrinology to contemporary disorders. Eur J Clin Investig. 2017;47:262–9.

    Article  Google Scholar 

  19. Gardelis JG, Hatzis TD, Stamogiannou LN, Dona AA, Fotinou AD, Brestas PS, et al. Activity of the growth hormone/insulin-like growth factor-I axis in critically ill children. J Pediatr Endocrinol Metab. 2005;18:363–72.

    Article  CAS  PubMed  Google Scholar 

  20. Gelato MC. The growth hormone/insulin-like growth factor axis in critical illness. J Pediatr Endocrinol Metab. 2000;13:S1023–9.

    Google Scholar 

  21. Van Dokkum NH, de Kroon MLA, Reijneveld SA, Bos AF. Neonatal stress, health, and development in preterms: a systematic review. Pediatrics. 2021;148:e202105414.

    Google Scholar 

  22. Yaribeygi H, Panahi Y, Sahraei H, Johnston TP, Sahebkar A. The impact of stress on body function: a review. EXCLI J. 2017;16:1057–72.

    PubMed  PubMed Central  Google Scholar 

  23. Halliday HL. The effect of postnatal steroids on growth and development. J Perinat Med. 2001;29:281–5.

    Article  CAS  PubMed  Google Scholar 

  24. Balany J, Bhandari V. Understanding the impact of infection, inflammation, and their persistence in the pathogenesis of bronchopulmonary dysplasia. Front Med. 2015;2:90.

    Article  Google Scholar 

  25. Thekkeveedu KR, Guaman MC, Shivanna B. Bronchopulmonary dysplasia: a review of pathogenesis and pathophysiology. Respir Med. 2017;132:170–7.

    Article  PubMed Central  Google Scholar 

  26. Curtiss J, Zhang H, Griffiths P, Shepherd EG, Lynch S. Nutritional management of the infant with severe bronchopulmonary dysplasia. NeoReviews. 2015;16:e674–9.

    Article  Google Scholar 

  27. Shepherd EG, Knupp AM, Welty SE, Susey KM, Gardner WP, Gest AL. An interdisciplinary bronchopulmonary dysplasia program is associated with improved neurodevelopmental outcomes and fewer rehospitalizations. J Perinatol. 2012;32:33–8.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We would like to thank Tara Benninger Ph.D., Emily Bingham RD, Jillane Downs MS, APRN, and Melissa Hanin MOT/L for their support and contributions.

Author information

Authors and Affiliations

Authors

Contributions

Each author made substantial contributions to conception and design. JC, TP, BLG, LL, MM, LP, KS, MS, and SL collected and contributed to the interpretation of the data. KGS analyzed and interpreted the data and reviewed and revised the final manuscript. JC drafted the initial manuscript and reviewed and revised the final manuscript. PG and TP reviewed and revised the initial draft. All authors approved the final version of the manuscript.

Corresponding author

Correspondence to Jennifer Curtiss.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Curtiss, J., Griffiths, P., Stephenson, K.G. et al. The Optimal State Scoring Tool: guidance for interdisciplinary care of infants with severe bronchopulmonary dysplasia and its relation to linear growth. J Perinatol 43, 1301–1307 (2023). https://doi.org/10.1038/s41372-023-01680-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41372-023-01680-x

Search

Quick links